Treatment of Vitamin B12 Deficiency
Initiate intramuscular hydroxocobalamin 1 mg immediately in all cases of severe vitamin B12 deficiency, with the specific regimen determined by whether neurological symptoms are present. 1
Immediate Pre-Treatment Assessment
Before starting therapy, screen every patient for neurological involvement by examining for: 1
- Sensory symptoms (pins-and-needles, numbness)
- Motor dysfunction and gait disturbances
- Balance problems causing falls
- Sensory ataxia
- Visual disturbances from optic nerve dysfunction
Critical Treatment Principles
Never delay treatment while awaiting specialist consultation or additional test results—begin intramuscular hydroxocobalamin immediately when severe deficiency is identified. 1, 2 The risk of irreversible subacute combined degeneration of the spinal cord outweighs any benefit of postponing therapy. 2
Do not give folic acid before correcting B12 deficiency, as it can mask the deficiency and precipitate permanent neurological damage. 1, 2
Treatment Regimens Based on Neurological Status
WITH Neurological Involvement
Loading Phase:
- Hydroxocobalamin 1 mg intramuscularly on alternate days 1, 2
- Continue until no further clinical improvement is observed (duration is not fixed) 1, 2
Maintenance Phase:
- Hydroxocobalamin 1 mg intramuscularly every 2 months for life 2
- Obtain urgent consultation from both a neurologist and hematologist 1, 2
WITHOUT Neurological Involvement
Loading Phase:
- Hydroxocobalamin 1 mg intramuscularly three times weekly for 2 weeks 2
Maintenance Phase:
- Hydroxocobalamin 1 mg intramuscularly every 2–3 months for life 2
Long-Term Management Considerations
Lifelong intramuscular therapy is mandatory regardless of symptom resolution. 1 The injection schedule should be individualized based on recurrence of symptoms (new sensory changes, fatigue, macrocytic anemia) rather than laboratory B12 levels alone. 1, 2 Clinical experience suggests up to 50% of patients require more frequent administration—ranging from daily to every 2–4 weeks—to remain symptom-free. 3
Alternative Routes for Non-Severe Cases
Oral vitamin B12 supplementation (high-dose) is noninferior to intramuscular therapy in patients without severe deficiency or neurological manifestations. 4 However, intramuscular administration remains preferred for malabsorption syndromes where oral supplementation is likely insufficient. 3
Sublingual methylcobalamin has demonstrated efficacy equal to or superior to intramuscular administration in raising serum B12 levels 5, though there is currently no evidence supporting that oral/sublingual preparations can safely replace injections in patients with established neurological involvement. 3
Common Pitfalls
Do not "titrate" injection frequency based on serum B12 or methylmalonic acid measurements—this practice lacks evidence and may lead to symptom recurrence. 3 Recognition of clinical symptoms must receive highest priority over laboratory values when adjusting maintenance therapy. 6